Synthetic peroxysome proliferator activated receptor-γ agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. - Yang,W-S.; Jeng,C-Y.; Wu,T-J.; Tanaka,S.; Funahashi,T.; Matsuzawa,Y.; Wang,J-P.; Chen,C-H.; Tay,T-Y.; Chuang,L-M. (Diabetes Care, 2002)